Thiago Carvalho on Nostr: "With the most potent weight-loss shot and a pipeline of 11 experimental treatments, ...
"With the most potent weight-loss shot and a pipeline of 11 experimental treatments, including what is widely expected to be the first approved small molecule GLP-1 pill, Eli Lilly stands to be the biggest winner in a market that is projected to grow to $130bn a year in peak sales by the end of the decade"
https://www.ft.com/content/ed81ca79-1fd6-48ea-8e50-246d0849c3f5Published at
2024-10-04 06:07:32Event JSON
{
"id": "6b9a131c0b638e2e58ceff0535f8f9170ddd288d0d882dd9df0eee65f67ab2a7",
"pubkey": "376d961fc946cb96839a4d257809dc9e6d237e2d0cc158199b8cc5c5771939a6",
"created_at": 1728022052,
"kind": 1,
"tags": [
[
"proxy",
"https://qoto.org/users/cyrilpedia/statuses/113247653242572000",
"activitypub"
]
],
"content": "\"With the most potent weight-loss shot and a pipeline of 11 experimental treatments, including what is widely expected to be the first approved small molecule GLP-1 pill, Eli Lilly stands to be the biggest winner in a market that is projected to grow to $130bn a year in peak sales by the end of the decade\"\n\nhttps://www.ft.com/content/ed81ca79-1fd6-48ea-8e50-246d0849c3f5",
"sig": "b01739d0aeb48d7ba8689265702a5e9978b9c71eedb453c3390e48a287436d2bdcf99f5a8e69fb13a39480262ad84a1724ce9cf6c7c736ae8b729d74934b7a7c"
}
